Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir baseline-versus-treatment study in relapsing-remitting multiple sclerosis
2012-004847-61Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltegravir in relapsing-remitting multiple sclerosis (RRMS), sponsored by Queen Mary University of London. Started Dec 2012; status: completed.
02
Drugs
raltegravir
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on 2012-004847-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004847-61.